Target intelligence / Profile preview

Son of sevenless homolog 2 (SOS2)

Target
SOS2
Molecular classification
Guanine nucleotide exchange factor (GEF), Enzyme, Signal transducer
01

Overview

Son of sevenless homolog 2 (SOS2) is a guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP on Ras family proteins, thereby activating Ras and propagating downstream signaling through pathways like PI3K/AKT and MAPK. SOS2 is structurally similar to SOS1 but has unique regulatory features and roles, notably impacting short-term activation of Ras and contributing to cellular proliferation and survival in response to growth factor signals. While SOS1 is considered the dominant GEF in most Ras-related pathologies, SOS2 also plays a critical role, particularly where SOS1 is deficient or absent, and has gained attention as a potential therapeutic target in RAS-driven cancers. Selective small molecule inhibitors against SOS2 have been developed, with quinazoline-based compounds demonstrating high selectivity and affinity for SOS2’s catalytic and interdomain sites. SOS2 is ubiquitously expressed and shares the Ras coupling function with SOS1, but exhibits distinct regulation and stability, impacting disease progression and therapeutic strategies

Other names
Son of sevenless homolog 2SOS2SOS-2NS9guanine nucleotide releasing factorson of sevenless homolog 2, guanine nucleotide releasing factor
02

Mechanism of action

Inhibition of guanine nucleotide exchange activity, preventing GDP-to-GTP exchange on Ras; Direct binding to catalytic and interdomain sites of SOS2, blocking its activation of Ras

03

Biological functions

Signal transductionActivation of Ras proteinsExchange of GDP for GTP on RasCellular proliferationCoupling of receptor tyrosine kinase (RTK) signals to Ras-dependent mitogenic pathways
04

Disease associations

Cancer (notably RAS-driven malignancies)Potential roles in hepatocellular carcinoma and other cancers associated with RAS pathway mutations
05

Safety considerations

Off-target or dual inhibition of SOS1/SOS2 may have unanticipated effects due to overlapping but distinct biological functionsLong-term inhibition might impact physiological signal transduction beyond cancer cellsNo specific clinical safety data available; preclinical issues could include abnormal cell proliferation and toxicity in non-target tissues
06

Interacting drugs

Quinazoline-based small molecule SOS2 inhibitors (selective for SOS2 over SOS1, e.g., 4-hydroxy aniline derivatives and additional optimized fragments)

2 more in the full profile.

07

Biomarkers

Mutations or expression levels of SOS2 in KRAS-driven cancers (potential but not established clinical biomarkers)RAS pathway genetic variants (research phase)

Beyond the preview

Go deeper on Son of sevenless homolog 2 (SOS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Son of sevenless homolog 2 (SOS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call